TURBT, or transurethral resection of bladder tumor, is a common, minimally invasive outpatient procedure used to diagnose, stage, and treat bladder cancer.

One benefit of BCG is that it targets cancer cells in your bladder and doesn’t have a negative effect on the rest of your body. Usually, BCG treatment is given after you have TURBT ...

Bladder cancer treatment continues to evolve, incorporating groundbreaking techniques to enhance survival rates and minimize side effects. Depending on the stage of the disease, ...

Bladder cancer is a serious, challenging disease, particularly when not detected early. [1] If the cancer spreads to nearby tissues, it's classified as locally advanced cancer.

The American Cancer Society estimates that 83,000 new cases of bladder cancer will be diagnosed this year. 17,000 will die from it. Others will have their bladders removed because of it.

About Bladder cancer is a common cancer and one of the most costly to treat, yet there has been little change in the standard of care in 40 years.

According to the American Cancer Society, over 83,000 new cases of bladder cancer are diagnosed among Americans each year, with almost 17,000 deaths linked to the disease.

In a medical milestone, UCLA surgeons completed the world's first in-human bladder transplant. Oscar Larrainzar had been struggling after having most of his bladder removed due to a tumor.

BCG treatment for bladder cancer not only acts locally but also reprograms bone marrow stem cells, enhancing the production of myeloid cells that strengthen innate immune responses against tumors.